|Age:||18 years or older|
|Keywords:||Non-Small Cell Lung Cancer, NSCLC, metastatic cancer, EGFR, poziotinib|
|Type:||Drug study, Phase 2|
Your study doctor will ask you questions and request medical tests to see if you qualify to be in the study. Your doctor will also evaluate your medical history, current and past medications, current and past medical symptoms, and the status of your cancer. This part of the study is called the screening period. It may take up to 30 days for you to complete all the required tests and evaluations before you can be treated in the study
The study is divided into periods of time for treatment called “cycles”. Each cycle is 28 days. Poziotinib (16 mg) is a pill or pills and will be taken orally once daily with breakfast at approximately the same time each morning. If the morning dose is missed, this dose may be taken any time during the day preferably with food, at least 8 hours prior to the next scheduled dose. On Cycle 2 Day 1, the daily dose will be taken at the clinic after the ECG is performed.
The study doctor will discuss the tests and procedures required for this study in greater detail.
Have any questions or want to learn more? Leave your contact details below and the research team will reach out to you.